Breast CancerA Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

Sponsor:

Hoffmann-La Roche

Code:

NCT04802759

Conditions

Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Giredestrant

Abemaciclib

Ipatasertib

Inavolisib

Ribociclib

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-21. This information was provided to ClinicalTrials.gov by Hoffmann-La Roche on 2026-08-05.